Literature DB >> 17376439

Effects of tau phosphorylation on proteasome activity.

Qing-Guo Ren1, Xiao-Mei Liao, Xiao-Qian Chen, Gong-Ping Liu, Jian-Zhi Wang.   

Abstract

Dysfunction of proteasome contributes to the accumulation of the abnormally hyperphosphorylated tau in Alzheimer's disease. However, whether tau hyperphosphorylation and accumulation affect the activity of proteasome is elusive. Here we found that a moderate tau phosphorylation activated the trypsin-like activity of proteasome, whereas further phosphorylation of tau inhibited the activity of the protease in HEK293 cells stably expressing tau441. Furthermore, tau hyperphosphorylation could partially reverse lactacystin-induced inhibition of proteasome. These results suggest that phosphorylation of tau plays a dual role in modulating the activity of proteasome.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17376439     DOI: 10.1016/j.febslet.2007.02.065

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  21 in total

1.  PGC-1α overexpression exacerbates β-amyloid and tau deposition in a transgenic mouse model of Alzheimer's disease.

Authors:  Magali Dumont; Cliona Stack; Ceyhan Elipenahli; Shari Jainuddin; Nathalie Launay; Meri Gerges; Natalia Starkova; Anatoly A Starkov; Noel Y Calingasan; Davide Tampellini; Aurora Pujol; M Flint Beal
Journal:  FASEB J       Date:  2014-01-07       Impact factor: 5.191

2.  High specificity of widely used phospho-tau antibodies validated using a quantitative whole-cell based assay.

Authors:  Dan Li; Yong Ku Cho
Journal:  J Neurochem       Date:  2019-09-04       Impact factor: 5.372

3.  Escitalopram Ameliorates Forskolin-Induced Tau Hyperphosphorylation in HEK239/tau441 Cells.

Authors:  Qing-Guo Ren; Yan-Juan Wang; Wei-Gang Gong; Qi-Da Zhou; Lin Xu; Zhi-Jun Zhang
Journal:  J Mol Neurosci       Date:  2015-02-17       Impact factor: 3.444

4.  Human tau may modify glucocorticoids-mediated regulation of cAMP-dependent kinase and phosphorylated cAMP response element binding protein.

Authors:  Yudong Liu; Ying Su; Shenggang Sun; Tao Wang; Xian Qiao; Hui Li; Xiaoqin Run; Zhihou Liang
Journal:  Neurochem Res       Date:  2012-05       Impact factor: 3.996

5.  Developmental Pathogenicity of 4-Repeat Human Tau Is Lost with the P301L Mutation in Genetically Matched Tau-Transgenic Mice.

Authors:  Julia E Gamache; Lisa Kemper; Elizabeth Steuer; Kailee Leinonen-Wright; Jessica M Choquette; Chris Hlynialuk; Kellie Benzow; Keith A Vossel; Weiming Xia; Michael D Koob; Karen H Ashe
Journal:  J Neurosci       Date:  2019-11-04       Impact factor: 6.167

6.  Tau Reduction Prevents Key Features of Autism in Mouse Models.

Authors:  Chao Tai; Che-Wei Chang; Gui-Qiu Yu; Isabel Lopez; Xinxing Yu; Xin Wang; Weikun Guo; Lennart Mucke
Journal:  Neuron       Date:  2020-03-02       Impact factor: 17.173

7.  Estradiol attenuates tau hyperphosphorylation induced by upregulation of protein kinase-A.

Authors:  Xin-An Liu; Ling-Qiang Zhu; Qi Zhang; Hai-Rong Shi; Shao-Hui Wang; Qun Wang; Jian-Zhi Wang
Journal:  Neurochem Res       Date:  2008-03-13       Impact factor: 3.996

8.  Lactacystin stimulates stellation of cultured rat cortical astrocytes.

Authors:  Qing-Guo Ren; Ying Yu; Deng-Ji Pan; Xiang Luo; Xue-Zhen Wang; Wei Wang
Journal:  Neurochem Res       Date:  2008-09-04       Impact factor: 3.996

9.  Characterization of proteasome inhibition on astrocytes cell cycle.

Authors:  Qing-Guo Ren; Ying Yu; Xiang Luo; Xie-Min Jie; Deng-Ji Pan; Wei Wang
Journal:  J Mol Neurosci       Date:  2008-12-09       Impact factor: 3.444

Review 10.  Tau hyperphosphorylation induces apoptotic escape and triggers neurodegeneration in Alzheimer's disease.

Authors:  Jian-Zhi Wang; Zhi-Hao Wang; Qing Tian
Journal:  Neurosci Bull       Date:  2014-03-14       Impact factor: 5.203

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.